Identification of the Tumor Antigen 90K Domains Recognized by Monoclonal Antibodies SP2 and L3 and Preparation and Characterization of Novel Anti-90K Monoclonal Antibodies

This publication has 17 references indexed in Scilit:

• Tumor-associated antigen 90K activates myelomonocytic cell line THP-1
  Cancer Letters, 1996
• The Immune Stimulatory Protein 90K Increases Major Histocompatibility Complex Class I Expression in a Human Breast Cancer Cell Line
  Biochemical and Biophysical Research Communications, 1996
• Elevated serum levels of 90K/MAC-2 BP predict unresponsiveness to α-interferon therapy in chronic HCV hepatitis patients
  Journal of Hepatology, 1996
• The 90K Tumor-Associated Antigen and Clinical Progression in Human Immunodeficiency Virus Infection
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 1995
• Prognostic value of a novel circulating serum 90K antigen in breast cancer
  British Journal of Cancer, 1994
• A 90-kDa Protein Serum Marker for the Prediction of Progression to AIDS in a Cohort of HIV-1⁺Homosexual Men
  AIDS Research and Human Retroviruses, 1993
• Cloning and characterization of cyclophilin C-associated protein: a candidate natural cellular ligand for cyclophilin C.
  Proceedings of the National Academy of Sciences, 1993
• CD44 is the principal cell surface receptor for hyaluronate
  Cell, 1990
• Measurement of a breast cancer associated antigen detected by monoclonal antibody SP-2 in sera of cancer patients
  Breast Cancer Research and Treatment, 1988
• Identification of a novel serum protein secreted by lung carcinoma cells
  Biochemistry, 1986